Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Bempikibart may help regrow hair in people with alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

PRP treatment may help with alopecia areata, especially in newer cases.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

A woman's hair loss and skin discoloration were found to be caused by a rare case of leprosy on the scalp, not alopecia-vitiligo overlap.

Impaired autophagy may contribute to alopecia areata.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Alopecia areata requires addressing both emotional and financial challenges for better patient care.

Trichoscopy is a useful tool for diagnosing and assessing the severity of alopecia areata.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The guideline provides recommendations for managing alopecia areata effectively.